pMSM14 [sng-1p::sng-1::eGFP::SspBmilli::ScBoNT/B(147-441, Y365A)::SL2::mCh::ScBoNT/B(1-146)::iLID(V416I)]
(Plasmid
#124067)
-
PurposeExpresses both parts of vesicular PaBoNT separately (SL2 trans-splicing site) under the control of the pan-neuronal C. elegans promoter sng-1p.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 124067 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Currently unavailable outside the U.S.
This material is available to academics and nonprofits only.
Backbone
-
Vector backbonepPD95_75
-
Backbone manufacturerAndrew Fire
- Backbone size w/o insert (bp) 3498
- Total vector size (bp) 11276
-
Vector typeBacterial Expression, Worm Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameVesicular Photoactivatable Botulinum Neurotoxin
-
Alt namevPaBoNT_worm
-
SpeciesC. elegans (nematode)
-
Insert Size (bp)6138
-
MutationBoNT (Y365A); SspB_milli (A57V and R73Q); iLID (V416I); S. cerevisiae codon-optimized
-
GenBank IDCP013243.1
- Promoter sng-1p
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer CATTTCATTCCAGCTCATTCCA
- 3′ sequencing primer CAGGGAGAAAGAGCATGTAG (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMSM14 [sng-1p::sng-1::eGFP::SspBmilli::ScBoNT/B(147-441, Y365A)::SL2::mCh::ScBoNT/B(1-146)::iLID(V416I)] was a gift from Alexander Gottschalk (Addgene plasmid # 124067) -
For your References section:
A Photoactivatable Botulinum Neurotoxin for Inducible Control of Neurotransmission. Liu Q, Sinnen BL, Boxer EE, Schneider MW, Grybko MJ, Buchta WC, Gibson ES, Wysoczynski CL, Ford CP, Gottschalk A, Aoto J, Tucker CL, Kennedy MJ. Neuron. 2019 Jan 15. pii: S0896-6273(19)30003-0. doi: 10.1016/j.neuron.2019.01.002. 10.1016/j.neuron.2019.01.002 PubMed 30704911